Single Ascending Dose Study of PRX003 in Healthy Subjects

Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

NCT03004339 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685

NCT05332704 ·Status: COMPLETED ·Phase: PHASE1

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects

NCT06033742 ·Status: COMPLETED ·Phase: PHASE1

AGN-242428 in the Treatment of Plaque Psoriasis

NCT03339999 ·Status: TERMINATED ·Phase: PHASE2

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects

NCT02976831 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

NCT02494479 ·Status: COMPLETED ·Phase: PHASE2

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

NCT02933866 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis

NCT06833307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

NCT02908347 ·Status: COMPLETED ·Phase: PHASE2

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

NCT00090129 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

NCT03895372 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

NCT02949388 ·Status: COMPLETED ·Phase: PHASE2

Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis

NCT03431974 ·Status: COMPLETED ·Phase: PHASE2

Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis

NCT00617994 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03832738 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

NCT01232283 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765

NCT00205465 ·Status: COMPLETED ·Phase: PHASE2

LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects

NCT00833872 ·Status: COMPLETED ·Phase: PHASE1

To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

NCT04566666 ·Status: COMPLETED ·Phase: PHASE2

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

NCT01309737 ·Status: COMPLETED ·Phase: PHASE3

A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis

NCT00778700 ·Status: COMPLETED ·Phase: PHASE2

A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

NCT03614078 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis

NCT01488201 ·Status: COMPLETED ·Phase: PHASE1

Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects

NCT06308393 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT01987843 ·Status: COMPLETED ·Phase: PHASE2